Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based biotech, was worth placing into a sprawling Phase 3 program.
Despite the turbulence of the past few years—pandemic, geopolitical conflict, inflation—climate change remains a top issue for technology, media, and telecommunications (TMT) companies. In fact, ...
VMS TMT IPO Day 1 Highlights: The initial public offering (IPO) of Thermo Mechanically Treated Bars (TMT Bars) manufacturer VMS TMT Ltd opened for subscription today, 17 September 2025, and will close ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results